Related references
Note: Only part of the references are listed.Interaction of graphene with antipsychotic drugs: Is there any charge transfer process?
Roxana M. del Castillo et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2021)
Analyzing the interaction energy between dopaminergic agents and DRD2: Is there any difference between risperidone (antagonist), aripiprazole (partial agonist) and pramipexole (agonist)?
Guillermo Goode-Romero et al.
COMPUTATIONAL AND THEORETICAL CHEMISTRY (2021)
In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
Osvaldo Yanez et al.
FRONTIERS IN CHEMISTRY (2021)
Conformational and electronic study of dopamine interacting with the D2 dopamine receptor
Rodrigo D. Tosso et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2020)
New information of dopaminergic agents based on quantum chemistry calculations
Guillermo Goode-Romero et al.
SCIENTIFIC REPORTS (2020)
Classics in Chemical Neuroscience: Chlorpromazine
Debra Boyd-Kimball et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Implementation of the Molecular Electrostatic Potential over Graphics Processing Units
J. Cesar Cruz et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Theoretical Study of the Antioxidant Activity of Quercetin Oxidation Products
Alejandro Vasquez-Espinal et al.
FRONTIERS IN CHEMISTRY (2019)
GPUs as boosters to analyze scalar and vector fields in quantum chemistry
Raymundo Hernandez-Esparza et al.
INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY (2019)
A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease
Ana Martinez et al.
PLOS ONE (2019)
Classics in Chemical Neuroscience: Risperidone
Trevor C. Chopko et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Current Concepts and Treatments of Schizophrenia
Piotr Stepnicki et al.
MOLECULES (2018)
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang et al.
NATURE (2018)
Challenges and opportunities for the development of new antipsychotic drugs
Carlos Forray et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Classics in Chemical Neuroscience: Ketamine
Marshall W. Tyler et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Peng Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Clozapine, a Fast-Off-D2 Antipsychotic
Philip Seeman
ACS CHEMICAL NEUROSCIENCE (2014)
Grid-Based Algorithm to Search Critical Points, in the Electron Density, Accelerated by Graphics Processing Units
Raymundo Hernandez-Esparza et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2014)
Classics in Chemical Neuroscience: Clozapine
Cody J. Wenthur et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Neurochemistry of Schizophrenia: The Contribution of Neuroimaging Postmortem Pathology and Neurochemistry in Schizophrenia
B. Dean
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation
Chiara Bianca Maria Platania et al.
PLOS ONE (2012)
A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu
Stefan Grimme et al.
JOURNAL OF CHEMICAL PHYSICS (2010)
Revealing Noncovalent Interactions
Erin R. Johnson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Quantum Chemistry on Graphical Processing Units. 3. Analytical Energy Gradients, Geometry Optimization, and First Principles Molecular Dynamics
Ivan S. Ufimtsev et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2009)
A multi-etiology model of systemic degeneration in schizophrenia
Anca Radulescu
JOURNAL OF THEORETICAL BIOLOGY (2009)
Emerging opportunities for antipsychotic drug discovery in the postgenomic era
Michael J. Marino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia
Jiri Horacek et al.
CNS DRUGS (2006)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists
MYS Kalani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Schizophrenia: Etiology and course
E Walker et al.
ANNUAL REVIEW OF PSYCHOLOGY (2004)
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
SG Potkin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Atypical antipsychotics: Mechanism of action
P Seeman
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2002)
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
J Geddes et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
